Clinical Trials and Research

Adults with sickle cell disease (SCD) face a substantial risk of stroke, most often in their 30s and 40s, with lasting physical disability and cognitive impairment…

Sickle cell anemia (SCA) is associated with substantial end‑organ morbidity, yet the circulating microRNA (miRNA) landscape in clinically stable, comorbidity‑free…

Hematologists-oncologists who specialize in sickle cell disease (SCD) report higher levels of burnout than those not specializing in SCD, even though no differences…

Sickle cell disease—the subject of a new Seminar in The Lancet—is one of the most prevalent and fastest-growing genetic disorders worldwide. Although its true…

Advanced genomic technologies are revolutionizing our ability to understand complex diseases. Large‐scale population studies are needed to realize the potential of…

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics, pH and food effect, and preliminary efficacy of BMS-…

Summary: Sickle cell disease (SCD) is widely recognized as a blood disorder, but new research reveals its profound impact on the brain’s architecture. Using…

National guidelines for the acute management of sickle cell disease (SCD) vaso-occlusive episodes (VOE) recommend use of a patient-specific (PSP) or a weight-based…

Sickle cell disease (SCD), an inherited blood disorder passed down through genes, shows up significantly more often in Black populations. In people with SCD, normal…

Rhys MayNorth Seattle Community Acupuncture and Wedgwood Acupuncture & Botanical MedicineKeywords:Case report, sickle cell anemia, pain, acupuncture,…